Mergers & Acquisitions Mergers & Acquisitions

Illumina sets aside $453 million for expected EU fine for closing takeover of Grail

By Nicholas Hirst
  • 11 Aug 2022 23:01
  • 11 Aug 2022 23:01
Illumina has set aside almost half a billion dollars to pay a fine from EU merger regulators for closing its acquisition of cancer-testing innovator Grail without receiving approval from the bloc.

The accrual comes after the European Commission formally accused Illumina with breaching EU law (see here), misconduct that can lead to

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News